You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Yale researchers said that they anticipate their RNA extraction-free saliva assay will make testing more scalable, affordable, and available to the public.
Replacing nasopharyngeal swabs with saliva samples or nasal swabs could increase throughput and convenience, as well as relieve reagent and equipment shortages.
Veracyte has obtained rights to a 52-gene signature developed by Yale researchers to predict disease progression in patients with idiopathic pulmonary fibrosis.
Under the EUA, the lab is authorized to detect SARS-CoV-2 in specimens collected from individuals suspected of having COVID-19 by their healthcare provider.
Cordlife Group, a Singapore-based consumer healthcare company, has partnered with US company PlumCare to offer genetic testing services in Asia.
The Yale professor said that deep-learning algorithms could give digital pathology the push it needs for broader adoption.
The team hopes to commercialize the technology by producing cost-effective tests to rapidly diagnose common upper respiratory viral pathogens.
The funding will be used to support the the newly established ME/CFS Collaborative Research Center at Stanford University.
The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge.
The planned instrument will help provide spatial information on both protein and RNA in tumor samples and will be powered by nCounter technology.